Apollo Hospitals has announced robust quarterly results. Revenue surged by 17% to 6,477 crores, with net profit climbing 35% to 502 crores. The hospital segment saw a 14% revenue increase. Expansion plans are on track, with new beds opening soon. The pharmacy network is the largest in India. Profitability across segments is strong.
Market experts note that Q3 earnings met expectations, with mid and smallcaps showing strong performance. Resolutions in US trade deals have boosted corporate confidence, especially for exporters. Analysts are optimistic about 2026, anticipating a better year than 2025 due to monetary and fiscal stimulus, lifted tariff uncertainties, and improved valuations, with a focus on stock-specific opportunities.
Samvardhana Motherson International's stock climbed following a strong third quarter profit rise. Analysts are optimistic, reiterating buy ratings and increasing price targets. The company's growth is fueled by acquisitions and organic expansion. Future prospects look bright with ambitious revenue goals and market positioning.
BHEL shares dropped nearly 5% to Rs 259.3 as the government launched an Offer for Sale (OFS) to divest up to 5% stake, aiming to raise approximately Rs 4,422 crore. The floor price is set at Rs 254 per share, a discount to Tuesday's closing. The offer opened for non-retail investors on Wednesday and for retail investors on Thursday.
The rupee weakened by 6 paise to 90.62 against the US dollar amid geopolitical tensions and importer demand. Fresh concerns arose from a US fact sheet detailing tariff reductions on Indian industrial and agricultural goods, impacting investor sentiment. Higher crude oil prices also add pressure on the Indian currency.
Budget 2026 introduced a one-time compliance window for undisclosed foreign assets, signaling a move towards structured cross-border investing. While trade deals with the US and EU offer sector-specific opportunities, India's premium valuations necessitate a focus on quality and growth. Currency volatility remains a key factor for global portfolios.
In the Nifty500 pack, 15 stocks' closing prices crossed above their 200 DMA (Daily Moving Averages) on February 10, 2026. Of these, we have highlighted 11 stocks that posted gains of more than 2%, according to stockedge.com's technical scan data. The 200-day daily moving average (DMA) is used by traders as a key indicator to determine the overall trend in a particular stock. As long as the stock is priced above the 200-day SMA on the daily timeframe, it is generally considered to be in an overall uptrend. Take a look:
Drawing a mixed bag of reactions from Indian investors, the US market outcome presented a dichotomy. The Dow Jones celebrated a new peak, yet the S&P 500 and Nasdaq ended on a down note. Attention turns towards forthcoming labor statistics, as heavy tech spending on artificial intelligence weighs on market psychology.
In today's fast-paced markets, Warren Buffett's wisdom emphasizes that long-term investing success hinges on sticking to a strategy rather than frequent trading. This patient approach allows compounding to work, enabling quality companies to grow and rewarding disciplined investors who focus on fundamentals amidst market volatility.
